- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MDVN Market Currents
more »
-
May 14 Medivation (MDVN +2%) moves up this morning after Citigroup added the stock to its Top Picks Live list and ratcheted up its price target to $129 from $90 after an upbeat meeting with management. Citi now believes enzalutamide's monthly price will be higher than expected, which will give a boost to margins in H212.
Comment![On the Move]
MDVN Related Articles
more »
MDVN News
more »
-
at CNBC.com (Apr 11, 2012)
-
at MarketWatch.com (Mar 8, 2012)
-
at MarketWatch.com (Feb 1, 2012)
-
at CNBC.com (Feb 1, 2012)
-
at MarketWatch.com (May 10, 2011)
MDVN Press Releases and Filings
more »
-
Marketwire (Mon, 7:55PM)
-
Marketwire (May 11, 2012)
-
Marketwire (May 8, 2012)
-
Marketwire (May 1, 2012)
-
Marketwire (Mar 19, 2012)
MDVN Latest Transcript
more »
-
Fri, Nov 5, 2010
MDVN Cramer
more »
MDVN Instablog posts
more »
MDVN vs. ETF Alternatives
Company Description
Currently, there's no company description for MDVN.
